PGEN: Precigen Inc
PGEN exchange rate has changed by -0.56% for today. During the day, the instrument was traded at a low of 7.08 and at a high of 7.27.
Follow Precigen Inc dynamics. Real-time quotes will help you quickly react to market changes. By switching between different timeframes, you can monitor exchange rate trends and dynamics by minutes, hours, days, weeks, and months. Use this information to forecast market changes and to make informed trading decisions.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
PGEN News
- ABBV's Etentamig Meets Goals in Phase III Multiple Myeloma Study
- Krystal Stock Gains 13.4% in a Month: What Is Driving the Rally?
- FDA Accepts UTHR's sNDA for Tyvaso in Idiopathic Pulmonary Fibrosis
- RARE Stock Down 46% as Phase III Angelman Syndrome Study Misses Goals
- TEVA's TEV '408 Meets Goal in Phase IIa Celiac Disease Study
- Here's Why You Should Add RNTX Stock to Your Portfolio Now
- OCGN Advances Gene Therapy OCU410 In Phase III for Geographic Atrophy
- AZN's Tagrisso Plus Orpathys Study in First-Line NSCLC Meets Goal
- KURA Stock Gains 37.6% in a Month: Here's What You Need to Know
- Here's Why You Should Add ARQT Stock to Your Portfolio Now
- Gilead Wins FDA Nod for Bixlenvo in Adults Living With HIV Infection
- FDA Accepts United Therapeutics' NDA Filing for Ralinepag in PAH
- BHVN Stock Soars 18% on $795M Out-Licensing Deal for Epilepsy Program
- Zacks Industry Outlook Halozyme, Repligen, Iovance, Arcutis and Precigen
- SYRE Stock Sinks After Mixed SKYWAY Study Data in Rheumatoid Arthritis
- 5 Biotech Stocks Worth Adding to Your Portfolio Now
- Here's Why You Should Add ACET Stock to Your Portfolio Now
- Anika Stock Gains 43.4% in the Past 3 Months: Here Is Why?
- TEVA's Ecopipam Wins FDA Priority Tag in Pediatric Tourette Syndrome
- Reasons Why Investors Should Consider Betting on PGEN Stock
- Nuvectis Stock Surges Around 97% in 3 Months: Here's Why
- ARGX Announces Positive Phase III Data on Vyvgart Hytrulo, Stock Up
- Are You Looking for a Top Momentum Pick? Why Precigen, Inc. (PGEN) is a Great Choice
- Precigen Stock Has To Grow Into Its Valuation (NASDAQ:PGEN)
Frequently Asked Questions
What is PGEN stock price today?
Precigen Inc stock is priced at 7.10 today. It trades within 7.08 - 7.27, yesterday's close was 7.14, and trading volume reached 3869. The live price chart of PGEN shows these updates.
Does Precigen Inc stock pay dividends?
Precigen Inc is currently valued at 7.10. Dividend policy depends on the company, while investors also watch 117.13% and USD. View the chart live to track PGEN movements.
How to buy PGEN stock?
You can buy Precigen Inc shares at the current price of 7.10. Orders are usually placed near 7.10 or 7.40, while 3869 and -0.28% show market activity. Follow PGEN updates on the live chart today.
How to invest into PGEN stock?
Investing in Precigen Inc involves considering the yearly range 2.99 - 7.72 and current price 7.10. Many compare 4.26% and 86.35% before placing orders at 7.10 or 7.40. Explore the PGEN price chart live with daily changes.
What are Precigen Inc stock highest prices?
The highest price of Precigen Inc in the past year was 7.72. Within 2.99 - 7.72, the stock fluctuated notably, and comparing with 7.14 helps spot resistance levels. Track Precigen Inc performance using the live chart.
What are Precigen Inc stock lowest prices?
The lowest price of Precigen Inc (PGEN) over the year was 2.99. Comparing it with the current 7.10 and 2.99 - 7.72 shows potential long-term entry points. Watch PGEN moves on the chart live for more details.
When did PGEN stock split?
Precigen Inc has gone through stock splits historically. These changes are visible in , 7.14, and 117.13% after corporate actions.
- Previous Close
- 7.14
- Open
- 7.12
- Bid
- 7.10
- Ask
- 7.40
- Low
- 7.08
- High
- 7.27
- Volume
- 3.869 K
- Daily Change
- -0.56%
- Month Change
- 4.26%
- 6 Months Change
- 86.35%
- Year Change
- 117.13%